Stock ENZY ENZYMOTEC LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Enzymotec Ltd.

Equities

ENZY

IL0011296188

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aker Biomarine Antarctic AS acquired Krill Oil Business of Enzymotec Ltd. for $26.4 million.
CI
Frutarom Ltd. completed the acquisition of the remaining 81.3% stake in Enzymotec Ltd. from Paulson & Co. Inc. and others for approximately $230 million.
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017
CI
Enzymotec Ltd. Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters
GL
Enzymotec Ltd. Announces Signed A Definitive Agreement with Frutarom Industries Ltd
CI
Enzymotec Ltd. acquired five nutritional supplements from Union Springs Healthcare, LLC for $27.9 million.
CI
Frutarom Ltd. acquired an additional 9.2% stake in Enzymotec Ltd. from Paulson & Co. Inc. for $24.2 million.
CI
Frutarom Industries Ltd. made an offer to acquire the remaining 81.3% stake in Enzymotec Ltd. from Paulson & Co. Inc. and others for approximately $220 million.
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017
CI
Enzymotec Ltd. Launches Krill Oil Product - K•REAL® Gold
CI
Enzymotec Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016
CI
Enzymotec Ltd. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2016
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016; Provides Earnings Guidance for 2016
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016; Provides Earnings Guidance for the Full Fiscal Year 2016
CI
Enzymotec Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016
CI
Enzymotec Ltd. Reaffirms Earnings Guidance for the Fiscal 2016
CI
Enzymotec Seeks Acquisitions
CI
Enzymotec Ltd. Receives Patents in U.S. for Compositions and Processes Related to Infant Nutrition and China for INFAT
CI
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Earnings Guidance for the Fiscal 2016
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENZY Stock
  4. News Enzymotec Ltd.
  5. Highlights